IL22 and Hepatic fibrosis: Through the induction of HSC senescence, IL-22 agonism reduces liver fibrosis in mice treated with CCl4, protects hepatocytes from damage during acute hepatitis, and alleviates hepatic inflammation in mice with acute-on-chronic liver failure 97.